Blocking a protein called Siglec-15 helped mice with brain tumors live longer
Original title: Siglec-15 and PD-1 checkpoint blockade in combination with oncolytic Zika virus infection confers protection against immune-resistant gliomas.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done in animals, not people. Most findings at this stage never become treatments.
The survival results were only seen in mice.
The short version
In mice with brain tumors, adding a drug that blocks a protein called Siglec-15 to two other treatments helped more of them survive.
What was studied. Researchers checked human glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary samples for a protein called Siglec-15, which sits on tumor cells and on some immune cells. They then treated mice that had brain tumors with an antibody that blocks Siglec-15, a tumor killing Zika virus, and a drug called anti-PD-1.
What they found. In the human samples, Siglec-15 was found on 16-22% of myeloid immune cells and 18-19% of tumor cells, and higher levels went with shorter survival. In mice, Zika virus plus the Siglec-15 blocker raised long term survival to 60%, compared with 40% for Zika virus alone. Adding the anti-PD-1 drug raised it to 83%, and in a second mouse tumor model all three together gave a 76% long term survival rate.
What this means, and what it doesn't
What it could mean: This does not change care today. It points to a possible new way to help the immune system fight glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. A Siglec-15 blocker is already being tested in people with a type of lung cancer, so that part of the idea is not brand new.
What it doesn't mean: This is not a cure, and it is not something you can ask a doctor for. The survival numbers came from mice, not from people. No one has tested this three part combination in a person with a brain tumor. Many treatments that work in mice do not work in people, and it would take years of human trials to find out.
Source: PubMed, August 8, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.